KRTAP13-3 inhibitors refer to a class of chemical compounds designed to target and modulate the activity of keratin-associated protein 13-3 (KRTAP13-3), a member of the keratin-associated protein family. KRTAP proteins are integral to the structure and formation of hair and other keratinized tissues, where they bind to keratin filaments to form complex structural frameworks. Inhibitors of KRTAP13-3 typically function by interacting with the protein at specific sites to modulate its binding affinity to keratin filaments or disrupt its ability to maintain structural integrity in these tissues. These inhibitors are usually small molecules or peptides that can directly interfere with KRTAP13-3's conformation, thus altering its interaction dynamics with keratin, which may affect the biophysical properties of hair or other keratin-rich tissues.
The chemical structures of KRTAP13-3 inhibitors vary depending on their mechanism of action. Many contain functional groups capable of forming hydrogen bonds or hydrophobic interactions with key amino acid residues in the KRTAP13-3 protein. In some instances, inhibitors may target the protein's active or binding sites, preventing the protein from engaging in its normal structural functions. By altering the interaction between KRTAP13-3 and keratin filaments, these inhibitors can influence the assembly and cross-linking of keratin networks, potentially affecting the mechanical properties of the tissue. The study of these inhibitors provides insight into how KRTAP proteins contribute to the structural biology of keratinized tissues and the molecular interactions governing their formation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could downregulate KRTAP13-3 by enforcing a compact chromatin structure, hindering transcription factor binding and transcriptional initiation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By reducing DNA methylation levels near the KRTAP13-3 gene, 5-Azacytidine might decrease the gene's expression by enabling transcriptional activation. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat may downregulate KRTAP13-3 expression by decreasing histone methylation, leading to a less permissive state for gene transcription. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 could lead to an increase in repressive histone methylation marks at the KRTAP13-3 locus, thereby inhibiting its transcription. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 may decrease KRTAP13-3 expression by preventing histone acetylation, leading to a chromatin environment less conducive to gene transcription. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib has the potential to downregulate KRTAP13-3 by inhibiting kinase-driven signaling pathways that promote its gene expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib might inhibit KRTAP13-3 expression by disrupting the degradation of transcriptional repressors, enhancing their ability to suppress the gene's transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D could inhibit RNA polymerase II, leading to a broad decrease in gene expression, including a reduction in KRTAP13-3 transcription levels. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone might reduce KRTAP13-3 expression by activating glucocorticoid receptors that bind to the gene's promoter region and recruit co-repressors. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, all trans could decrease KRTAP13-3 expression through activation of retinoic acid receptors, which might then bind to the gene's promoter and suppress transcription. | ||||||